Pneumonia News and Research

Latest Pneumonia News and Research

Lilly, Merck announce another immuno-oncology collaboration

Eli Lilly and Company and Merck, known as MSD outside the United States and Canada, today announced another immuno-oncology collaboration that will evaluate abemaciclib (LY2835219), Lilly's cyclin-dependent kinase (CDK) 4 and 6 inhibitor, and Merck's KEYTRUDA (pembrolizumab) in a Phase I study across multiple tumor types.

10 Dec 2015

More than half of U.S. hospitals don't require flu shots for staff, new study finds

Within weeks, flu will start spreading across North America, sickening millions of people. It will hit people with health problems and weak immune systems hardest, and may kill tens of thousands of them.

10 Dec 2015

New study shows wide disparities in access to minimally invasive hysterectomies for uterine cancer

A new study led by Johns Hopkins researchers shows wide racial and economic disparities in access to minimally invasive hysterectomies for early uterine cancer in the United States. This is despite years of accumulating evidence that the procedures to remove the uterus are linked to fewer postoperative complications, the researchers say.

9 Dec 2015

Maternal smoking affects long-term health of male offspring

Mothers who smoke are putting more than their own health at risk, suggests a study published today in BJOG: an International Journal of Obstetrics and Gynaecology. Young men whose mothers smoked during pregnancy had lower aerobic fitness compared to those whose mothers did not.

9 Dec 2015

Takeda presents Phase 3 TOURMALINE-MM1 data for multiple myeloma at ASH 2015

Takeda Pharmaceutical Company Limited today announced results from the TOURMALINE-MM1 trial presented at the 57th Annual Meeting and Exposition of the American Society of Hematology (ASH), showing that treatment with NINLARO (ixazomib) capsules is effective in extending progression free survival (PFS) with a manageable tolerability profile in patients with relapsed and/or refractory multiple myeloma.

8 Dec 2015

FIRS calls for continued international support to end AIDS epidemic by 2030

World AIDS Day, held annually on the first day of December each year since 1988, is an opportunity for people around the world to join in the fight, show their support for those living with human immunodeficiency virus (HIV), and commemorate the lives of those who have died.

7 Dec 2015

FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

Today the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple myeloma who have received one to three prior medications.

30 Nov 2015

WPI researchers awarded $1.3 million NIH grant to study use of copper to battle bacterial invader

Copper is an essential micronutrient that all organisms need to maintain healthy metabolism. But unless it is bound to proteins, copper is also toxic to cells. With a $1.3 million award from the National Institutes of Health, researchers at Worcester Polytechnic Institute will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. aeruginosa), a leading cause of hospital-associated infections that is increasingly resistant to antibiotics, with the hope of discovering new drug targets that might allow cells in the body to use copper to fight back against this bacterial invader.

25 Nov 2015

Scientists create detailed image of deadly toxin linked to bacterial pneumonia, meningitis, septicaemia

Scientists from the University of Leicester have for the first time created a detailed image of a toxin - called pneumolysin - associated with deadly infections such as bacterial pneumonia, meningitis and septicaemia.

25 Nov 2015

People who experience persistent heartburn despite over-the-counter treatments need to check with their doctors

If Thanksgiving makes you wince at the thought of impending heartburn pain, you are probably not alone. But if you experience heartburn more than twice a week despite over-the-counter treatments, a Jefferson expert wants you to check with your doctor. Gastroesophageal Reflux Disease (GERD) Awareness Week is observed each year during the week of Thanksgiving, a fitting time as Americans prepare to indulge in the holiday season.

23 Nov 2015

SLU infectious diseases experts answer flu season questions

A cure for the common cold isn't in the crystal ball of an infectious diseases researcher and physician at Saint Louis University's Center for Vaccine Development.

23 Nov 2015

Last resort antibiotics may no longer work

E.coli has become resistant to the last line of antibiotics we have left and untreatable bugs may already be circulating in Britain, warn scientists.

19 Nov 2015

Lilly, Merck expand oncology clinical trial collaboration

Eli Lilly and Company and Merck, known as MSD outside the United States and Canada, today announced the extension of an existing collaboration to evaluate the safety and efficacy of the combination of Lilly's ALIMTA (pemetrexed for injection) and Merck's KEYTRUDA (pembrolizumab) in a pivotal Phase III study in first-line nonsquamous non-small cell lung cancer (NSCLC).

19 Nov 2015

Women & Infants Hospital recognized as 2014 Top Performer on Key Quality Measures

Women & Infants Hospital of Rhode Island, a Care New England hospital, announced today that it has been recognized as a 2014 Top Performer on Key Quality Measures by The Joint Commission, the leading accreditor of health care organizations in the U.S.

19 Nov 2015

Measles vaccination plays key role in reducing child mortality

The number of measles-related deaths has decreased 79% from 546 800 at the beginning of the century to 114 900 in 2014. New data released by WHO for the Measles & Rubella Initiative, estimates that 17.1 million lives have been saved since 2000, largely due to increased vaccination coverage against this highly contagious viral disease.

13 Nov 2015

Drug combination produces long-term responses in patients with mantle cell lymphoma

New research from Moffitt Cancer Center and its collaborators find that the drug combination rituximab plus lenalidomide was effective and produced long-term responses in patients with mantle cell lymphoma.

13 Nov 2015

Common ingredient in sunscreen can prevent infections related to medical implants

A common ingredient in sunscreen could be an effective antibacterial coating for medical implants such as pacemakers and replacement joints.

11 Nov 2015

Phase I clinical trial shows investigational anticancer therapeutic is safe, tolerable in lymphoma patients

Results from a phase I clinical trial showed that the first-in-class, investigational, anticancer therapeutic pevonedistat was safe, tolerable, and had some anticancer activity in heavily pretreated patients with relapsed/refractory lymphoma.

11 Nov 2015

Paratek initiates Omadacycline phase 3 clinical study in community acquired bacterial pneumonia (CABP)

Paratek Pharmaceuticals, Inc. has announced the dosing of the first patient in its Phase 3 clinical study of its lead drug candidate, omadacycline, for the treatment of Community Acquired Bacterial Pneumonia (CABP). This global Phase 3 study will assess the efficacy and safety of omadacycline compared with moxifloxacin in subjects with CABP.

9 Nov 2015

Combatting viral and bacterial lung infections with volatile anesthetics: an interview with Dr Chakravarthy

Inhaled anesthetics are fairly common all over the world for minor and extensive surgical procedures in patients of all age groups. In the olden days when anesthesia was first developed, ether was the first inhaled anesthetic. That has been replaced, with the more recent discoveries of sevoflurane, isoflurane, and desflurane.

9 Nov 2015

Pneumonia News and Research

Latest Pneumonia News and Research

Lilly, Merck announce another immuno-oncology collaboration

More than half of U.S. hospitals don't require flu shots for staff, new study finds

New study shows wide disparities in access to minimally invasive hysterectomies for uterine cancer

Maternal smoking affects long-term health of male offspring

Takeda presents Phase 3 TOURMALINE-MM1 data for multiple myeloma at ASH 2015

FIRS calls for continued international support to end AIDS epidemic by 2030

FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

WPI researchers awarded $1.3 million NIH grant to study use of copper to battle bacterial invader

Scientists create detailed image of deadly toxin linked to bacterial pneumonia, meningitis, septicaemia

People who experience persistent heartburn despite over-the-counter treatments need to check with their doctors

SLU infectious diseases experts answer flu season questions

Last resort antibiotics may no longer work

Lilly, Merck expand oncology clinical trial collaboration

Women & Infants Hospital recognized as 2014 Top Performer on Key Quality Measures

Measles vaccination plays key role in reducing child mortality

Drug combination produces long-term responses in patients with mantle cell lymphoma

Common ingredient in sunscreen can prevent infections related to medical implants

Phase I clinical trial shows investigational anticancer therapeutic is safe, tolerable in lymphoma patients

Paratek initiates Omadacycline phase 3 clinical study in community acquired bacterial pneumonia (CABP)

Combatting viral and bacterial lung infections with volatile anesthetics: an interview with Dr Chakravarthy

Industry Focus eBook - Forensics & Toxicology (1st edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Pneumonia News and Research

Latest Pneumonia News and Research

Industry Focus eBook - Forensics & Toxicology (1st edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in